Walgreens Boots Alliance Inc. Announces Q2 Financial Results

On Tuesday, Walgreens Boots Alliance Inc. revealed its second-quarter financial performance for fiscal 2025, showcasing a 3.9% increase in total sales, reaching $38.6 billion. This growth not only surpassed the previous year's figures but also exceeded analysts' expectations.

Financial Highlights and Challenges

The company managed to reduce its net loss significantly, from $12.3 billion in the second trimester of 2024 to $4 billion this quarter. Similarly, the net loss per diluted share improved to $3.30, down from $6.85 a year ago. Despite these improvements, weaker front-end results in U.S. Retail Pharmacy and significant legal settlements contributed to continued negative free cash flow.

CEO's Perspective on Future Growth

"Our second-quarter results demonstrate disciplined cost management and notable progress in U.S. Healthcare. However, we acknowledge that we are still in the early stages of our turnaround plan. Meaningful value creation will require time," stated CEO Tim Wentworth. Following the earnings announcement, Walgreens' stock experienced a 1.96% increase in premarket trading.